Value Sense
MASI
Masimo Corporation (MASI)
Last Price$190.61.0%
Market Cap$10.4B
LTM PEG 1Y
0.7x
5Y avg
0.4x
Medical - Instruments & Supplies industry median
0.1x
Stock quality & Intrinsic value
5/10
(0.3%) overvalued
MASI
is (26.6%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Masimo Corporation PEG 1Y

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'07Jan'09Dec'09Dec'10Dec'11Dec'12Dec'13Jan'15Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
PEG 1Y
0.3x
0.2x
0.3x
0.1x
0.1x
0.1x
0.2x
0.1x
0.2x
0.2x
0.1x
0.2x
0.3x
0.4x
0.4x
0.3x
0.4x
MASI
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for MASI and see if it's the right time to invest.
Dive in

Masimo Corporation (MASI) PEG 1Y comparison analysis

General

LTM PEG 1Y

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Masimo Corporation logo
Masimo CorporationMASI
(0.2x)
0.6%
(42.5%)
4.0%
Median Peer Set
0.8x
3.4%
23.0%
10.4%
AptarGroup, Inc. logo
AptarGroup, Inc.ATR
5.9x
2.7%
30.2%
10.5%
Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc.ISRG
4.3x
17.2%
27.7%
27.8%
West Pharmaceutical Services, Inc. logo
West Pharmaceutical Services, Inc.WST
3.2x
(1.9%)
(15.5%)
17.0%
Alcon Inc. logo
Alcon Inc.ALC
0.9x
8.5%
182.9%
10.3%
ResMed Inc. logo
ResMed Inc.RMD
0.8x
10.9%
13.4%
21.8%
Hologic, Inc. logo
Hologic, Inc.HOLX
0.7x
(0.0%)
81.1%
19.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
0.5x
8.4%
32.2%
10.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.3x
4.2%
18.3%
8.4%
Repligen Corporation logo
Repligen CorporationRGEN
(3.1x)
(21.1%)
(80.9%)
5.6%
Baxter International Inc. logo
Baxter International Inc.BAX
N/A
(69.5%)
(100.0%)
(6.9%)

MASI key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'04Dec'05Dec'06Dec'07Jan'09Jan'10Jan'11Dec'11Dec'12Dec'13Jan'15Jan'16Dec'16Dec'17Dec'18Dec'19Jan'21Jan'22Dec'22Dec'23
Revenue
% growth
69.4
0.0%
107.9
55.6%
224.3
107.9%
256.3
14.2%
307.1
19.8%
349.1
13.7%
405.4
16.1%
439.0
8.3%
493.2
12.4%
547.2
11.0%
586.6
7.2%
630.1
7.4%
694.6
10.2%
798.1
14.9%
858.3
7.5%
937.8
9.3%
1,143.7
22.0%
1,239.2
8.3%
2,035.8
64.3%
2,048.1
0.6%
Cost of Goods Sold (COGS)0.042.761.673.689.5100.3119.8144.9167.0188.4195.9220.1230.8263.0283.4308.7400.7430.8977.01,044.6
Gross Profit
% margin
69.4
100.0%
65.2
60.4%
162.7
72.5%
182.7
71.3%
217.6
70.9%
248.8
71.3%
285.6
70.4%
294.1
67.0%
326.3
66.1%
358.8
65.6%
390.8
66.6%
410.0
65.1%
463.8
66.8%
535.1
67.0%
574.9
67.0%
629.2
67.1%
743.1
65.0%
808.3
65.2%
1,058.8
52.0%
1,003.5
49.0%
Operating Expenses0.053.4(146.2)115.7146.3166.6179.4207.6241.0271.1297.6309.3313.0337.7366.4408.0487.7532.5848.8867.0
Research & Development Expenses (R&D)0.08.524.923.025.531.736.038.447.155.656.656.659.462.077.093.3118.7137.2191.4175.2
Selling, General & Administrative Expenses (SG&A)0.043.191.591.2120.1134.9143.4169.2193.9215.5241.0252.7253.7275.8289.5314.7369.1395.3657.4664.0
Operating Income
% margin
69.4
100.0%
16.3
15.2%
45.8
20.4%
67.2
26.2%
71.2
23.2%
82.3
23.6%
104.9
25.9%
86.5
19.7%
85.2
17.3%
79.7
14.6%
103.5
17.6%
120.3
19.1%
420.8
60.6%
197.4
24.7%
208.0
24.2%
221.2
23.6%
255.8
22.4%
275.8
22.3%
210.0
10.3%
136.5
6.7%
Interest Income0.00.00.00.02.30.20.00.00.00.00.00.00.00.00.013.95.50.91.83.0
Interest Expense0.09.00.00.00.20.10.00.31.117.40.00.00.00.00.00.30.30.425.750.3
Pre-tax Income0.07.4314.468.172.482.2107.686.583.875.7102.0116.3418.3199.4213.8234.2263.7274.4193.488.1
Income Tax
% effective tax rate
73.2
0.0%
(26.0)
(353.0%)
132.6
42.2%
25.9
38.0%
40.5
55.9%
28.2
34.3%
34.2
31.8%
22.5
26.0%
21.9
26.1%
20.0
26.4%
27.7
27.1%
34.8
29.9%
117.7
28.1%
67.8
34.0%
20.2
9.5%
38.0
16.2%
23.5
8.9%
44.7
16.3%
49.9
25.8%
6.6
7.5%
Net Income
% margin
(3.8)
(5.5%)
33.4
30.9%
181.8
81.1%
42.3
16.5%
31.9
10.4%
53.2
15.2%
73.5
18.1%
63.7
14.5%
62.3
12.6%
58.4
10.7%
72.5
12.4%
83.3
13.2%
300.7
43.3%
131.6
16.5%
193.5
22.5%
196.2
20.9%
240.3
21.0%
229.6
18.5%
143.5
7.0%
81.5
4.0%
EPS(0.41)0.573.790.710.570.921.251.071.081.031.331.626.282.423.453.674.394.162.681.54
Diluted EPS(0.41)0.423.040.600.530.881.211.051.071.021.301.555.852.233.453.444.143.982.601.51
EBITDA
% margin
69.4
100.0%
19.3
17.9%
49.4
22.0%
72.5
28.3%
78.9
25.7%
88.2
25.3%
114.2
28.2%
93.8
21.4%
94.6
19.2%
99.1
18.1%
106.0
18.1%
134.4
21.3%
(102.4)
(14.7%)
203.8
25.5%
229.6
26.8%
259.0
27.6%
293.8
25.7%
310.9
25.1%
355.2
17.4%
236.7
11.6%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Masimo Corporation's PEG 1Y?

As of today, Microsoft Corp's last 12-month PEG 1Y is 0.7x, based on the financial report for Dec 27, 2024 (Q4’2024). The average annual PEG 1Y for Masimo Corporation have been 0.4x over the past three years, and 0.4x over the past five years.

2) Is Masimo Corporation's PEG 1Y Good?

As of today, Masimo Corporation's PEG 1Y is 0.7x, which is higher than industry median of 0.1x. It indicates that Masimo Corporation's PEG 1Y is Bad.

3) How does Masimo Corporation's PEG 1Y compare to its peers?

As of today, Masimo Corporation's PEG 1Y is 0.7x, which is lower than peer median of 0.8x. The list of peers includes ATR, ISRG, WST, ALC, RMD, HOLX, COO, BDX, RGEN, BAX.